NAMS   $20.125  0.57% Market Closed After Close 20.12 -0.02%

NewAmsterdam Pharma Company NV
Total Cash 430.71M
totalCashPerShare 4.785
EBITDA -208.63M
Total Debt 562.00K
quickRatio 9.626
currentRatio 9.83
Total Revenue 7.42M
debtToEquity 0.145
Revenue/Share 0.085
ROA -0.27145
ROE -0.54077
grossProfits
freeCashflow -108.42M
operatingCashflow -188.63M
earningsGrowth
revenueGrowth 0.327
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -23.06933
profitMargins 0.0
enterpriseValue 1.10B
forwardPE -10.241379
floatShares 33.89M
sharesOutstanding 90.02M
sharesShort 548.71K
sharesShortPriorMonth 422.47K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.86%
Short Ratio help_outline 2.12%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 4.304
Price To Book help_outline 4.14
earningsQuarterlyGrowth
netIncomeToCommon -229.40M
trailingEps -2.62%
forwardEps -1.74%
enterpriseToEbitda -5.28
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.5 3Q 2024
institutionsCount 117
lastUpdated Nov. 2, 2024, 2:08 a.m.